Professional Background
Marketing Director | Pharmaceutical
Santiago, Chile
Global specialty pharmaceutical company. Portfolio of 54 brands, revenue of €110M.
Lead Strategic Marketing and P&L ownership for a promotional and non-promotional portfolio across retail and tender channels, spanning OTC, prescription, food supplements, and dermatological brands. Member of the Local Board.
Commercial Head — LATAM South Pacific | Pharmaceutical
Global pharmaceutical company. Responsible for full commercial operations in Chile, Ecuador, and Peru across three business units: Primary Care, Vaccines, and HIV.
Managed $150M net revenue (£13M) across three business units and two commercial channels (private and public/tender). Led end-to-end P&L, investment allocation, Joint Business Planning with key accounts, and full sales team leadership.
General Manager — Personal Health Care | FMCG
Santiago, Chile
Fortune 500 FMCG and consumer health company. Managed the Personal Health Care Business Unit for Chile — OTC and prescription portfolio with focus on retail channel.
Full P&L ownership (~$30M) across sales management, marketing strategy, investment planning, pricing, channel expansion, and talent development. Led a team of 45 people.
Commercial Excellence Head | Pharmaceutical
Pacific Cluster
Global pharmaceutical and consumer health company. Andean and South Pacific Region operations across Colombia, Peru, Chile, and Ecuador.
Commercial Excellence Head — Andean Region Jul 2016 – Oct 2018 · Bogotá, Colombia
Built and led the Commercial Excellence function from scratch across four countries, overseeing omnichannel strategy, CRM deployment, targeting, and sales force capability development.
Marketing Manager — Consumer Health Oct 2013 – Jun 2016 · Quito, Ecuador
Managed the Consumer Health product portfolio in Ecuador, covering brand strategy, promotional and sales budget, product launches, and forecasting.
Regional Product Manager | Medical Devices
Colombia / Ecuador
Global medical products company. Managed the Renal Business Unit across Ecuador, Colombia, and Peru — tender negotiations, market access, and patient therapy expansion.
-
Expanded access to renal disease therapies reaching an additional 10% of the affected patient population through strategic tender agreements.
-
Coordinated market access strategies in Ecuador and Colombia, engaging key opinion leaders and institutional accounts.